334.75 USD
-0.08 (-0.02%)
334.8 USD
+0.05 (+0.01%)
We assign a fundamental rating of 6 out of 10 to SWAV. SWAV was compared to 184 industry peers in the Health Care Equipment & Supplies industry. SWAV is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SWAV is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes SWAV very considerable for growth investing!
1. Profitability
1.1 Basic Checks
- In the past year SWAV was profitable.
- SWAV had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: SWAV reported negative net income in multiple years.
- In multiple years SWAV reported negative operating cash flow during the last 5 years.
1.2 Ratios
- The Return On Assets of SWAV (9.95%) is better than 93.23% of its industry peers.
- SWAV has a better Return On Equity (21.76%) than 95.31% of its industry peers.
- SWAV's Return On Invested Capital of 8.81% is amongst the best of the industry. SWAV outperforms 88.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 21.76% | ||
| ROIC | 8.81% |
ROA(3y)13.4%
ROA(5y)-1.2%
ROE(3y)20.17%
ROE(5y)0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 20.76%, SWAV belongs to the top of the industry, outperforming 94.79% of the companies in the same industry.
- SWAV has a better Operating Margin (20.52%) than 94.27% of its industry peers.
- Looking at the Gross Margin, with a value of 86.99%, SWAV belongs to the top of the industry, outperforming 96.35% of the companies in the same industry.
- In the last couple of years the Gross Margin of SWAV has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.52% | ||
| PM (TTM) | 20.76% | ||
| GM | 86.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.99%
GM growth 5Y16.42%
2. Health
2.1 Basic Checks
- SWAV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, SWAV has more shares outstanding
- SWAV has a worse debt/assets ratio than last year.
2.2 Solvency
- SWAV has an Altman-Z score of 10.26. This indicates that SWAV is financially healthy and has little risk of bankruptcy at the moment.
- SWAV's Altman-Z score of 10.26 is amongst the best of the industry. SWAV outperforms 86.98% of its industry peers.
- The Debt to FCF ratio of SWAV is 4.41, which is a neutral value as it means it would take SWAV, 4.41 years of fcf income to pay off all of its debts.
- SWAV has a better Debt to FCF ratio (4.41) than 82.81% of its industry peers.
- A Debt/Equity ratio of 0.97 indicates that SWAV is somewhat dependend on debt financing.
- SWAV's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. SWAV is outperformed by 76.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 4.41 | ||
| Altman-Z | 10.26 |
ROIC/WACC0.94
WACC9.36%
2.3 Liquidity
- A Current Ratio of 13.81 indicates that SWAV has no problem at all paying its short term obligations.
- SWAV's Current ratio of 13.81 is amongst the best of the industry. SWAV outperforms 97.92% of its industry peers.
- SWAV has a Quick Ratio of 12.61. This indicates that SWAV is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 12.61, SWAV belongs to the top of the industry, outperforming 97.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.81 | ||
| Quick Ratio | 12.61 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 12.34% over the past year.
- Looking at the last year, SWAV shows a very strong growth in Revenue. The Revenue has grown by 41.44%.
- Measured over the past years, SWAV shows a very strong growth in Revenue. The Revenue has been growing by 126.31% on average per year.
EPS 1Y (TTM)12.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.81%
Revenue 1Y (TTM)41.44%
Revenue growth 3Y120.84%
Revenue growth 5Y126.31%
Sales Q2Q%35.85%
3.2 Future
- The Earnings Per Share is expected to grow by 17.56% on average over the next years. This is quite good.
- SWAV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.10% yearly.
EPS Next Y36.11%
EPS Next 2Y27.65%
EPS Next 3Y24.15%
EPS Next 5Y17.56%
Revenue Next Year27.69%
Revenue Next 2Y24.82%
Revenue Next 3Y23.61%
Revenue Next 5Y20.1%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 78.21, which means the current valuation is very expensive for SWAV.
- Compared to the rest of the industry, the Price/Earnings ratio of SWAV indicates a somewhat cheap valuation: SWAV is cheaper than 67.19% of the companies listed in the same industry.
- SWAV is valuated expensively when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 53.09, the valuation of SWAV can be described as expensive.
- Based on the Price/Forward Earnings ratio, SWAV is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
- SWAV is valuated expensively when we compare the Price/Forward Earnings ratio to 25.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.21 | ||
| Fwd PE | 53.09 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, SWAV is valued a bit cheaper than the industry average as 67.19% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, SWAV is valued a bit cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.65 | ||
| EV/EBITDA | 66.43 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SWAV does not grow enough to justify the current Price/Earnings ratio.
- SWAV has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as SWAV's earnings are expected to grow with 24.15% in the coming years.
PEG (NY)2.17
PEG (5Y)N/A
EPS Next 2Y27.65%
EPS Next 3Y24.15%
5. Dividend
5.1 Amount
- No dividends for SWAV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SHOCKWAVE MEDICAL INC / SWAV FAQ
What is the fundamental rating for SWAV stock?
ChartMill assigns a fundamental rating of 6 / 10 to SWAV.
What is the valuation status for SWAV stock?
ChartMill assigns a valuation rating of 4 / 10 to SHOCKWAVE MEDICAL INC (SWAV). This can be considered as Fairly Valued.
What is the profitability of SWAV stock?
SHOCKWAVE MEDICAL INC (SWAV) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for SWAV stock?
The Earnings per Share (EPS) of SHOCKWAVE MEDICAL INC (SWAV) is expected to grow by 36.11% in the next year.